Literature DB >> 11015381

Detection of borreliacidal antibodies in dogs after challenge with Borrelia burgdorferi-infected ixodes scapularis ticks.

S M Callister1, D A Jobe, R F Schell, S D Lovrich, K L Onheiber, J B Korshus.   

Abstract

Detection of borreliacidal antibodies is an accurate serodiagnostic test for confirmation of Lyme disease in humans. In this study, 13 pathogen-free beagles, 12 to 26 weeks old, were infected with Borrelia burgdorferi by tick challenge. Dogs were monitored for clinical signs and symptoms of Lyme disease along with borreliacidal antibody production against B. burgdorferi sensu stricto isolates 297 and 50772. Ten (77%) dogs developed lameness in one or more legs within 210 days after attachment of Ixodes scapularis ticks. Eight (80%) of the lame animals had concurrent fever of > or =38 degrees C. Spirochetes were also recovered from the skin and joints of 12 (92%) dogs, but rarely from other organs. Borreliacidal antibodies against B. burgdorferi isolate 297 were detected in only four (31%) dogs, and the levels of killing antibodies remained low for the duration of the infection. In contrast, borreliacidal antibodies against B. burgdorferi isolate 50772 were detected in 13 (100%) dogs within 21 days of infection. Furthermore, the borreliacidal antibody levels correlated with the severity of B. burgdorferi infection. Detection of borreliacidal antibodies, especially against B. burgdorferi isolate 50772, is also a reliable serodiagnostic test for detection of Lyme disease in dogs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11015381      PMCID: PMC87454     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Complement resistance in Borrelia burgdorferi strain 297: outer membrane proteins prevent MAC formation at lysis susceptible sites.

Authors:  K Patarakul; M F Cole; C A Hughes
Journal:  Microb Pathog       Date:  1999-07       Impact factor: 3.738

2.  Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi.

Authors:  S M Callister; K L Case; W A Agger; R F Schell; R C Johnson; J L Ellingson
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

3.  Protection elicited by native outer membrane protein Oms66 (p66) against host-adapted Borrelia burgdorferi: conformational nature of bactericidal epitopes.

Authors:  M M Exner; X Wu; D R Blanco; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

4.  Detection of borreliacidal antibodies by flow cytometry. An accurate, highly specific serodiagnostic test for Lyme disease.

Authors:  S M Callister; R F Schell; L C Lim; D A Jobe; K L Case; G L Bryant; P E Molling
Journal:  Arch Intern Med       Date:  1994-07-25

5.  Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.

Authors:  T G Schwan; J Piesman; W T Golde; M C Dolan; P A Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

6.  The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies.

Authors:  M Scriba; J S Ebrahim; T Schlott; H Eiffert
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

7.  Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.

Authors:  W S Probert; R B LeFebvre
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Experimental Lyme disease in dogs produces arthritis and persistent infection.

Authors:  M J Appel; S Allan; R H Jacobson; T L Lauderdale; Y F Chang; S J Shin; J W Thomford; R J Todhunter; B A Summers
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

9.  Lyme disease assay which detects killed Borrelia burgdorferi.

Authors:  S M Callister; R F Schell; S D Lovrich
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

10.  Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test.

Authors:  S M Callister; R F Schell; K L Case; S D Lovrich; S P Day
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

View more
  5 in total

1.  Humoral immune response in dogs naturally infected with Borrelia burgdorferi sensu lato and in dogs after immunization with a Borrelia vaccine.

Authors:  Michael W Leschnik; Georges Kirtz; Gelas Khanakah; Georg Duscher; Ernst Leidinger; Johann G Thalhammer; Anja Joachim; Gerold Stanek
Journal:  Clin Vaccine Immunol       Date:  2010-03-10

2.  Diversity of antibody responses to Borrelia burgdorferi in experimentally infected beagle dogs.

Authors:  Elisabeth Baum; Deborah A Grosenbaugh; Alan G Barbour
Journal:  Clin Vaccine Immunol       Date:  2014-04-02

3.  Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease.

Authors:  Steven D Lovrich; Rhonda L La Fleur; Dean A Jobe; Jennifer C Johnson; Krista E Asp; Ronald F Schell; Steven M Callister
Journal:  Clin Vaccine Immunol       Date:  2007-03-07

4.  Countrywide serological evaluation of canine prevalence for Anaplasma spp., Borrelia burgdorferi (sensu lato), Dirofilaria immitis and Ehrlichia canis in Mexico.

Authors:  Rebeca Movilla; Carlos García; Susanne Siebert; Xavier Roura
Journal:  Parasit Vectors       Date:  2016-07-29       Impact factor: 3.876

5.  Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.

Authors:  Deborah A Grosenbaugh; Karelle De Luca; Pierre-Yves Durand; Bradley Feilmeier; Kristopher DeWitt; Cecile Sigoillot-Claude; Marie-Line Sajous; Michael J Day; Frederic David
Journal:  BMC Vet Res       Date:  2018-10-16       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.